Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 6 days ago Drug news

Data for Exparel results in high rates of early discharge and patient satisfaction for total knee or hip arthroplasty

Pacira Pharmaceuticals, Inc. announced new data showing that a patient-optimizing, opioid-sparing enhanced recovery after surgery (ERAS) pathway, which includes intraoperative...

Added 5 days ago Drug news

FDA approves Dupixent to treat adolescents with atopic dermatitis

The FDA has approved Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose...

Added 3 hours ago Drug news

OG 217SC filed with the FDA for type 2 diabetes

Novo Nordisk announced the submission of two New Drug Applications (NDAs) to the FDA for OG 217SC (oral semaglutide), the...

Added 3 hours ago Drug news

Ozempic filed with FDA for risk reduction in MACE

Novo Nordisk has filed a supplemental NDA (sNDA) with the FDA for once-weekly Ozempic (semaglutide) injection 0.5 mg or 1...

Industry news

Added 2 days ago Industry news

Alcon acquires Power Vision Inc., provider of fluid based intraocular lens implants

Alcon, announced that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular...

Added 13 days ago Industry news

GTx Inc acquired by Oncternal Therapeutics

GTx, Inc.and Oncternal Therapeutics, Inc., a privately held clinical-stage biotechnology company developing potential first-in-class therapeutic candidates for cancers with critical...

Added 15 days ago Industry news

Pacira Pharma acquires Myoscience Inc and with it iovera system a non opioid treatment for pain control

Pacira Pharmaceuticals, Inc. and MyoScience, Inc. a privately held medical technology company, announced the signing of a definitive agreement for...